Market Mastery

Webinar by Vishal Malkan

Find the weak links

in your portfolio by Vishal Malkan

Foreign investors have bought Rs 84,000 crore of Indian stocks in November, a record for any month, marking a sharp reversal from heavy selling as domestic equities court favour amid cooling crude prices, resilient earnings and a retreat from global AI-linked stocks.

However, an analyst said "this is an early sign of renewed confidence, but not yet a full structural return".

Prasenjit Paul – Fund Manager at 129 Wealth & Research Analyst at Paul Asset said, "FPIs still remain net sellers of roughly Rs 2.1 lakh crore in 2026 despite the November buying. For flows to sustain, crude needs to soften, macro conditions must improve and earnings should reflect that improvement next year. Till then, the market will remain selective, with stronger earnings and reasonable valuations deciding which stocks can hold their gains."

He added that the current phase of FPI buying is still mainly concentrated in largecaps and index-heavy stocks. "The recovery is not broad-based yet. Normally, a rally starts with largecaps, and if foreign flows sustain, it should gradually spread to midcaps and smallcaps."

Regarding the DII selling seen recently, Paul said, "DIIs absorbed heavy foreign selling over the last two years, so some profit booking after the recent rally is quite normal. This looks tactical rather than a change in their long-term view, as monthly SIP inflows were still Rs 32,160 crore in October with nearly 10 crore contributing accounts. Once this profit booking is over, steady domestic inflows should make DIIs net buyers again."

The NSE Nifty 50 is up 9.5% so far this month, while the BSE Sensex has gained 10.1%, putting the benchmark indexes on track for their best monthly gains in six years.

This (FII buying) looks like the early stage of a gradual structural shift, helped by more reasonable large-cap valuations after the market correction and easing crude prices. The Rs 84,290 crore inflow follows combined selling of over Rs 70,000 crore in September and October, so foreign investors are partly correcting their underweight position, Paul added.

Regarding the triggers market investors should track for next three-six months, he said: "Crude oil remains the most important trigger for us. Brent fell nearly 13% in the first week of November to around $97 a barrel, and that itself helped improve foreign flows and market sentiment. Once oil falls further and stabilises at a lower level, inflation, the rupee and earnings expectations can improve together, opening the door for a market re-rating."

While the surge has helped Indian equities recoup some of their losses relative to regional peers, the Nifty 50 is still down 3.5% for the year, with India among the worst performing markets in Asia.

Brokerages including Citi, HSBC and Goldman Sachs have become more optimistic about Indian stocks as investors rotate away from AI-heavy markets in South Korea and Taiwan.

"We see strong credit growth, resilient earnings and measures supporting growth and the currency," HSBC analysts led by Herald van der Linde said in note last week, adding that India offers diversification and lower volatility compared to Asian markets dominated by AI stocks.

Still, sustaining the rally will require steady earnings growth to support India's valuation premium, said Angela Lan, senior strategist at State Street Investment Management.

The Nifty 50 trades at 19 times its 12-month forward earnings, a premium to its Asian and emerging-market peers.

Heavyweight financials have led sectoral gains in November, with financial services, banks, private banks and state-owned lenders rising between 11.5% and 13.5%.

HDFC Bank, the heaviest-weighted stock on the Nifty 50, has surged 17%, partially reversing its year-to-date losses, while ICICI Bank has climbed 13.5% after upbeat quarterly results reinforced expectations of improving loan growth and easing margin pressure.

Financials are particularly well placed as credit growth picks up and margin pressures ease, alongside domestic consumption and EV-linked automakers, said Peeyush Mittal, portfolio manager at Matthews Asia.

Other top performers include the auto index, which has risen 8.7% this month. Heavyweight Mahindra & Mahindra has advanced 17.2% in November, helped by a quarterly profit beat due to resilient SUV demand.

"We have been positive on pharma since early 2026, and it remains our preferred sector. It offers a better mix of defensive demand and company-specific earnings triggers, while the banking rally is partly driven by renewed flows and short covering. Within pharma also, investors should remain selective and focus on improving earning prospects rather than buying the entire sector," said Paul.

With inputs from Reuters